Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–8 of 8 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT03011814
- Conditions
- Folliculotropic Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT03017820
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Bone Marrow Diseases, +46 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT07003100
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +19 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
NCT02702310
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
- Locations
-
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
NCT04074746
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +21 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma
NCT02520791
- Conditions
- Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +29 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
- Yale University New Haven, Connecticut, United States
Active, Not Recruiting
Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas
NCT03598998
- Conditions
- Anaplastic Large Cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, +35 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
Active, Not Recruiting
Study of Pembrolizumab (MK-3475) in Combination With Romidepsin
NCT03278782
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +23 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States